Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT07224789
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- cf-circRNA assay — DIAGNOSTIC_TESTCircular RNA detection in plasma or serum by RT-qPCR
Study Details
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. This study aims to develop a non-invasive liquid biopsy assay using plasma-derived cell-free circular RNAs (cf-circRNAs) for early and accurate detection of colorectal cancer.
Key Dates
- Start date
- Jan 15, 2025
- Status verified
- Nov 2025
- Primary completion
- Jun 18, 2026
- Completion
- Jun 18, 2026
Study Design
- Enrollment
- 600 participants (estimated)
Arms
- Arm: Colorectal Cancer - Training CohortPatients with histologically confirmed colorectal adenocarcinoma (Stage I-III) enrolled in the training set. Plasma samples are collected before any surgery or therapy for cf-circRNA profiling.
- Arm: Non-Disease Control - Training CohortHealthy individuals with no prior malignancy or major systemic disease, age- and sex-matched to the CRC group, included in the training set.
- Arm: Colorectal Cancer - Validation CohortIndependent cohort of patients with histologically confirmed colorectal adenocarcinoma (Stage I-III) from separate institutions, used to validate the diagnostic cf-circRNA signature. Plasma obtained prior to treatment.
- Arm: Non-Disease Control - Validation CohortIndependent cohort of healthy participants without malignant or inflammatory bowel disease, serving as external validation controls.
Primary Outcome Measure
Sensitivity [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Goel Ajay, PhD626-218-3452
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91016 |
Find similar trials in Duarte, CA
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPHASE1 · Recruiting · BioEclipse Therapeutics · Scottsdale, Arizona